Skip to main content
. Author manuscript; available in PMC: 2022 Feb 19.
Published in final edited form as: ACS Chem Biol. 2021 Feb 3;16(2):277–282. doi: 10.1021/acschembio.1c00026

Figure 3.

Figure 3.

Behavioral and pharmacokinetic results in vaccinated and unvaccinated mice administered carfentanil or fentanyl. Baseline nociception was measured, then mice received two consecutive intraperitoneal 200 μg/kg bolus doses of carfentanil, t = 0 and t = 15 min, and latency to nociception was measured at 15 min intervals in the hot plate (A) and tail flick (B) tests. Significance is denoted by an asterisk from a two-way RM ANOVA with Bonferroni’s post hoc test when comparing vaccinated groups to unvaccinated (control), *P < 0.05, **P < 0.01, ***P < 0.001 versus control. Mice were dosed with 20 μg/kg of carfentanil, then trunk blood (C) and the brain (D) were harvested 15 min postinjection and carfentanil was quantified by LCMS analysis. **P < 0.01 and ***P < 0.001 versus control determined by one-way ANOVA. Mice were cumulatively dosed with fentanyl, and latency to nociception was measured by hot plate (E) and tail flick (F) tests. (G) Calculated ED50 values for fentanyl antinociception activity. Statistical comparison was made by one-way ANOVA with a Tukey’s post hoc test, ***P < 0.001 versus control group; #P < 0.05, #P < 0.01 versus other vaccine group. (H) Potency ratios determined for each vaccine group relative to the control group. Dashed line denotes control level. #P < 0.05 two-tailed t-test. Bars denote means ± SEM in all plots; n = 6 per group for all studies.